Notes

A fund manager reviewed six names for primary receipts, replacing 205, and exited with a status of 0. The fund is called Catalyst Research, and it has a size of 0. The receipts are compact and originated from the PRE91108 archive. The review occurred on 2026-09-15 at 05:01:04.396044+00:00. The manager looked at several panels of information, including a news scan that found the headline 'Tamboran Delivers First Gas Sales From the Beetaloo Basin' from TBNnews on September 8, 2026, and a blog post from Neovolta on home battery safety on September 9, 2026. The manager also reviewed a FDA approval announcement from Scholar Rock on September 11, 2026, and a corporate calendar from Tamboran. The manager made decisions on several stocks, including SRRK, NEOV, and TBN, with specific actions planned for September 22, 23, and 25.

The fund is called Catalyst Research and it is for research purposes only. The fund size is 0 and the time is 2026-09-15T03:31:08.942170+00:00 UTC. There are several news updates: TLX on Sunday, September 13, 2026, announced that the FDA approved Telix's brain cancer imaging drug Pixclara, which can be found at https://telixpharma.com/news-views/fda-approves-telixs-brain-cancer-imaging-drug-pixclara/. AVO on Tuesday, September 8, 2026, announced its fiscal 2026 third-quarter financial results, which can be found at https://investors.missionproduce.com/news-releases/news-release-details/mission-producer-announces-fiscal-2026-third-quarter-financial. ABM on Tuesday, September 8, 2026, reported its fiscal third-quarter 2026 results, which can be found at https://abm.gcs-web.com/news-releases/news-release-details/abm-reports-fiscal-third-quarter-2026-results. ROIV on Tuesday, September 8, 2026, announced positive results from the Phocus study of mosliciguat, which can be found at https://investor.roivant.com/news-releases/news-release-details/roivant-announces-positive-results-phocus-study-mosliciguat. There are also several financial filings: UNFI filed a 10-K on September 14, 2026, which can be found at 0001020859-26-000025/unfi-20260801.htm, DRI filed a 10-K on July 24, 2026, which can be found at 0000940944-26-000025/dri-20260531.htm, PPIH filed a 10-Q on September 9, 2026, which can be found at 0001437749-26-029988/ppih20260731_10q.htm, MRK filed a 10-Q on August 7, 2026, which can be found at 0000310158-26-000212/mrk-20260630.htm, and WLTH filed a 10-Q on September 14, 2026, which can be found at 0001628280-26-061848/wlth-20260731.htm. EPM announced a $0.12 per share cash dividend on Thursday, September 10, 2026, which can be found at https://ir.evolutionpetroleum.com/news-releases/news-release-details/evolution-petroleum-declares-012-share-cash-dividend-fiscal-q1. IPHA filed a 6-K on September 10, 2026, which can be found at 0001628280-26-061214/a260910_6k.htm. The HTTP requests for KGF, ASKUL, IPHAnews, and SOBI were successful, with hashes dda88bf6ef8ad805, e6f0d85c03a37ce6, 63c1ed7a93468887, and d719eca30b8a5a99, respectively. The research is strong for new information and weak or absent for old information, with a decision to cash out and reverify weak or absent information. There is a conditional receipt for Sobi and Q1 2028. The monitors for 165, 168, 167, and 137, and 22 are preserved. There are no orders and the sources and dates can be found in the job script and journal.

A fund manager reviewed notes from the Catalyst research fund, which has a size of 0 and compact receipts originating from the PRE91108 archive, as of 2026-09-15T02:46:10.171114+00:00. The manager looked at six pieces of information, or panels, which included a news headline from TBNnews about Tamboran delivering first gas sales from the Beetaloo Basin, a filing from CNXC, a blog post from NEOV about home battery safety, an announcement from Scholar Rock about FDA approval of a drug called ISEMBYLD, a corporate calendar from TBN, and a group of stocks including SRRK, SCHL, and PRAX. The manager also saw a preview of these panels, which included a schedule 13G filing, a UTC time of 2026-09-15T02:46:07.964357+00:00, and a sha, or secure hash algorithm, of 86bbe1eb4739333e. A news scan found the headline 'Tamboran Delivers First Gas Sales From the Beetaloo Basin' and the manager took note of the ticker symbols CNXC, NEOV, SRRK, and TBN.

A fund manager's notes were recorded on 2026-09-15T01:16:06.579464+00:00. The fund is called Catalyst Research and its size is 0. The notes are a compilation of compact receipts from various sources, including the PRE91108 archive. The notes include a list of panels with previews of information from the SEC, including HITI and BFRI, and other sources such as Dave & Buster's quarterly report and information about TSM, CAN, and EGTX. A news scan found the headline 'Dave & Buster’s Reports Second Quarter 2026' on Mon, 14 Sep 2026 16:05:00 -0400. The notes also mention a photodynamic therapy system and a suspension being lifted on Sep 1. The information is based on previews, and the originals should be read before taking any action.

The Catalyst fund is currently in research mode only, with a size of 0, as of September 15, 2026, at 01:16:00 UTC. The fund is monitoring the following stocks: IONS, MIRM, GIS, EAT, and CAG. The fund manager has reviewed SEC filings for IONS on September 4, 2026, MIRM on September 8, 2026, GIS on July 1, 2026, and EAT on August 12, 2026. On September 9, 2026, Barclays maintained an overweight rating on Ionis Pharmaceuticals and lowered its price target to $85. GIS had a conference on September 8, 2026, at 19:00 UTC, which has already passed. The fund is waiting for the replay. GIS is expected to release its earnings on September 23, 2026, at 13:00 UTC, with a Q&A session, but the exact time of the first release is unknown. The fund will review the earnings and verify the cash flow and guidance. If the organic cash flow is strong, the fund will record and validate the results. If the cash flow is weak or absent, the fund will reverify the results. The fund has a baseline estimate for GIS's FY27 EPS of $3.00-3.20, with organic growth of -1.5% to +0.5%, and savings of $750 million. The fund has frozen its paper window from September 16 to September 21 and has a calendar out-of-sample performance of +0.567% and a stress performance of -2.405%. The fund is also monitoring EAT, which had an investor day on August 31, 2026, and is expected to release its earnings on October 28, 2026. The fund will review the earnings and reverify the first news release. The fund has a frozen T5 holdout of -19.2065% and will not make any automatic trades. The fund manager has chosen to review the earnings and investor day presentations for EAT on September 17, 2026, at 16:30 UTC and October 28, 2026, at 16:30 UTC, respectively. The fund is in research mode only and has not placed any orders as of September 15, 2026, at 01:16:03 UTC.

The Catalyst fund, which is for research only and has a size of 0, was updated on September 15, 2026, at 01:16:01 UTC. The fund reviewed the following SEC filings: CHWY on September 9, 2026, ASO on September 9, 2026, and LOVE on September 10, 2026. It also reviewed an 8-K filing from SFIX on July 28, 2026. Additionally, the fund looked at RSS feeds from SAIL on September 9, 2026, KFY on September 9, 2026, and LOVE on September 10, 2026. The fund also checked the FDA website for information on GRAL, which has a meeting scheduled for September 23, 2026. The fund will review new morning results on September 9 at 12:30, LOVE on September 10 at 12:30, and SFIX on September 24 at 12:30, after the September 23 AMC. The GRAL panel on September 23 is not for approval. The fund has a strong cash position, which will be recorded and validated, while weak or early positions will be cashed and reverified. No automatic orders were made.

A fund manager reviewed six names for primary receipts, replacing 205 with an exit code of 0. The fund is called Catalyst Research, with a size of 0, and has its origins in the PRE91108 archive, with a timestamp of 2026-09-15T00:46:09.461397+00:00. The manager reviewed seven panels, including information on CNXC, with a filing date of 2026-08-14 and a form called SCHEDULE 13G, which is a type of securities filing. The manager also looked at news from TBN, including an article about Tamboran delivering first gas sales from the Beetaloo Basin, and a corporate calendar from the same company. Additionally, the manager reviewed information on NEOV, including a blog post about home battery safety, and SRRK, including an announcement about FDA approval of a drug called ISEMBYLD. The manager made decisions based on this information, including exiting a position in NEOV on September 22 and planning to exit a position in TBN on September 25.

The fund is called Catalyst Research and it is for research only. The size of the fund is 0 and the time is 2026-09-14T23:30:58.468791+00:00. There are several news updates: TLX on Sunday, September 13, 2026, announced that the FDA approved Telix's brain cancer imaging drug Pixclara, which can be found at https://telixpharma.com/news-views/fda-approves-telixs-brain-cancer-imaging-drug-pixclara/. AVO on Tuesday, September 8, 2026, announced its fiscal 2026 third quarter financial results, which can be found at https://investors.missionproduce.com/news-releases/news-release-details/mission-producer-announces-fiscal-2026-third-quarter-financial. ABM on Tuesday, September 8, 2026, reported its fiscal third quarter 2026 results, which can be found at https://abm.gcs-web.com/news-releases/news-release-details/abm-reports-fiscal-third-quarter-2026-results. ROIV on Tuesday, September 8, 2026, announced positive results from the Phocus study of mosliciguat, which can be found at https://investor.roivant.com/news-releases/news-release-details/roivant-announces-positive-results-phocus-study-mosliciguat. There are also several financial reports: UNFI's 10-K report for 2026, which can be found at 0001020859-26-000025/unfi-20260801.htm, DRI's 10-K report for 2026, which can be found at 0000940944-26-000025/dri-20260531.htm, PPIH's 10-Q report for 2026, which can be found at 0001437749-26-029988/ppih20260731_10q.htm, MRK's 10-Q report for 2026, which can be found at 0000310158-26-000212/mrk-20260630.htm, and WLTH's 10-Q report for 2026, which can be found at 0001628280-26-061848/wlth-20260731.htm. EPM announced a $0.12 per share cash dividend on Thursday, September 10, 2026, which can be found at https://ir.evolutionpetroleum.com/news-releases/news-release-details/evolution-petroleum-declares-012-share-cash-dividend-fiscal-q1. IPHA's 6-K report for 2026 can be found at 0001628280-26-061214/a260910_6k.htm. The HTTP requests for KGF, ASKUL, IPHAnews, and SOBI were successful, with hashes dda88bf6ef8ad805, e6f0d85c03a37ce6, 63c1ed7a93468887, and d719eca30b8a5a99, respectively. The research is strong for IPHA, which is scheduled for September 17, and Sobi, which has a conditional receipt for Q1 2028. The monitors for 165, 168, 167, 137, and 22 should be preserved. There are no orders and the sources and dates can be found in the job script and journal. The research should be verified by reading the originals and validating the information, especially for weak or absent information, and cash should be used to reverify any errors.

The fund is called Catalyst Research and it is for research only. It has a size of 0 and it is a compact receipt. The information comes from the PRE91108 archive. On September 14, 2026, at 22:46:01, the system recorded the following information. There are seven panels of information. The first panel has 71 characters and a unique code d8ada1dced09830d. The second panel has 736 characters and a unique code 35b7328fdf758a56, and it mentions TBN news from September 8, 2026, about Tamboran delivering first gas sales from the Beetaloo Basin. The third panel has 483 characters and a unique code 9b319fcc0f6464f5, and it mentions a company called CNXC and a filing date of August 14, 2026. The fourth panel has 416 characters and a unique code 6003fc75312f424f, and it mentions a US Australian event. The fifth panel has 1708 characters and a unique code 14f74c5483bcfd2a, and it mentions Scholar Rock announcing FDA approval of a product called ISEMBYLD. The sixth panel has 2979 characters and a unique code 20a893bcb14321a6, and it mentions a company called Neov and a blog post about home battery safety. The seventh panel has 325 characters and a unique code 6abd1fe877acb858, and it mentions groups of companies including SRRK, SCHL, and PRAX, and it mentions exit strategies for September 22 and September 25. The system has finished recording the information and there are no errors. The unique code for all the panels is c42108698135571db9e6f2f309dd5ceedcbbc5472dfc15ebce3df706afeeecd2.

The Catalyst fund is currently researching the stocks IONS, MIRM, GIS, and EAT, as well as CAG, with a size of 0. The fund's status was updated on September 14, 2026, at 21:15:59 UTC. The fund manager has been reviewing SEC filings for these stocks, including IONS on September 4, MIRM on September 8, GIS on July 1, and EAT on August 12. A news scan found the headline that Barclays maintains an overweight rating on Ionis Pharmaceuticals and lowers its price target to $85 on September 9. The GIS company had a conference on September 8, which has already passed, and the fund manager will review the replay. The fund manager is also waiting for the earnings report of GIS on September 23, which will include a Q&A session at 13:00 UTC. The fund manager will review the earnings report and verify the cash flow and guidance. The baseline for GIS is an EPS of $3.00-3.20 and organic growth of -1.5% to +0.5% for the fiscal year 2027. The fund manager has also been reviewing the stock EAT and its investor day on September 17 and earnings call on October 28. The fund manager will review the earnings report and verify the cash flow and guidance. The fund is currently in research mode only and has not placed any orders. The fund manager will verify the full pipelines and early news for the stocks before making any decisions.

The Catalyst fund, which is for research only and has a size of 0, was updated on September 14, 2026, at 21:15:57 UTC. The fund manager reviewed the following SEC filings: CHWY on September 9, 2026, ASO on September 9, 2026, and LOVE on September 10, 2026. The manager also reviewed an 8-K filing from SFIX on July 28, 2026. Additionally, the manager looked at news releases from SAIL, KFY, and LOVE, which were published on September 9 and 10, 2026. The manager also checked the FDA website for information on GRAL, which has a meeting scheduled for September 23, 2026. The manager noted that SEC filings may lag behind news and will review results on September 9 and 10, and SFIX on September 24. The manager also noted that the GRAL meeting on September 23 is not for approval. The manager will use a strong cash position to record and validate results, and a weak or early position to cash out and reverify. No automatic orders were placed.

A fund manager reviewed notes from the Catalyst research fund, which has a size of 0 and compact receipts. The notes originated from the PRE91108 archive and were last updated on 2026-09-14T20:31:02.087122+00:00. The notes include six panels of information. The first panel is about the fund itself. The second panel mentions a news article from TBNnews on September 8, 2026, about Tamboran delivering first gas sales from the Beetaloo Basin. The third panel refers to a filing from CNXC on August 14, 2026. The fourth panel links to a corporate calendar on the Tamboran website. The fifth panel announces FDA approval of a drug called ISEMBYLD on September 11, 2026, by Scholar Rock. The sixth panel discusses home battery safety from Neovolta on September 9, 2026, and includes trading decisions for stocks SRRK, NEOV, and TBN. The notes end with a summary of the seven panels and a warning to read the originals before taking action.

The Catalyst research fund has a size of 0 as of 2026-09-14T19:30:56.710278+00:00 UTC. Recent news includes: TLX on Sun, 13 Sep 2026, where the FDA approved Telix's brain cancer imaging drug Pixclara, which can be found at https://telixpharma.com/news-views/fda-approves-telixs-brain-cancer-imaging-drug-pixclara/. AVO announced fiscal 2026 third-quarter financial results on Tue, 08 Sep 2026, available at https://investors.missionproduce.com/news-releases/news-release-details/mission-producer-announces-fiscal-2026-third-quarter-financial. ABM reported fiscal third-quarter 2026 results on Tue, 08 Sep 2026, at https://abm.gcs-web.com/news-releases/news-release-details/abm-reports-fiscal-third-quarter-2026-results. ROIV announced positive results from the Phocus study of mosliciguat on Tue, 08 Sep 2026, found at https://investor.roivant.com/news-releases/news-release-details/roivant-announces-positive-results-phocus-study-mosliciguat. Recent filings include UNFI's 10-K on 2026-09-14, DRI's 10-K on 2026-07-24, PPIH's 10-Q on 2026-09-09, MRK's 10-Q on 2026-08-07, and WLTH's 8-K on 2026-09-09. EPM declared a $0.12 share cash dividend on Thu, 10 Sep 2026, at https://ir.evolutionpetroleum.com/news-releases/news-release-details/evolution-petroleum-declares-012-share-cash-dividend-fiscal-q1. IPHA filed a 6-K on 2026-09-10. HTTP requests returned the following hashes: KGF with hash dda88bf6ef8ad805, ASKUL with hash e6f0d85c03a37ce6, IPHAnews with hash 63c1ed7a93468887, and SOBI with hash d719eca30b8a5a99. The fund will preserve monitors 165, 168, 167, 137, and 22. No orders were placed. Research is ongoing, with a focus on reading originals and validating information for strong and new data, and cashing and re-verifying weak or absent data. IPHA has a conditional receipt and Q1-2028 condition on Sep 17.

The fund is called Catalyst Research and it is for research only. It has a size of 0 and it is a compact receipt. The information comes from the PRE91108 archive. The update was made on 2026-09-14 at 18:15:59.701982+00:00. There are six panels of information. The first panel has 71 characters and a unique code of ac70cbce864373af. The second panel has 736 characters and a preview of a news article from TBNnews about Tamboran delivering first gas sales from the Beetaloo Basin. The third panel has 483 characters and a preview of a filing from CNXC, which is a stock ticker, with a filing date of 2026-08-14. The fourth panel has 416 characters and a preview of an event from Tamboran. The fifth panel has 1708 characters and a preview of an announcement from Scholar Rock about FDA approval of a drug called ISEMBYLD. The sixth panel has 2979 characters and a preview of a blog post from Neovolta about home battery safety. The seventh panel has 325 characters and a preview of a group of stocks, including SRRK, SCHL, and PRAX, and a decision to exit a call option for NEOV on September 22 and a call option for TBN on September 25.

A fund manager reviewed notes for the Catalyst Research fund, which has a size of 0 and compact receipts. The origins of the fund are in the PRE91108 archive, and the review was done on 2026-09-14T17:16:05.203265+00:00. The manager looked at various panels, including SEC filings for HITI on 2026-08-31 and BFRI on 2026-09-14. They also reviewed news about Dave & Buster's Entertainment, Inc. and TSM, as well as information about EGTX and its conferences. Additionally, they checked the USITC website for information about BFRI and photodynamic therapy systems. The manager also noted that the ITC lifted a suspension on BFRI on September 1, 2026. The review consisted of 11 panels, and the manager advised reading the originals before taking action.

The Catalyst fund is currently in research mode only, with a size of 0, as of September 14, 2026, at 17:01:14 UTC. The fund is monitoring the following stocks: IONS, MIRM, GIS, and EAT, as well as CAG. The fund manager has preserved 126 positions with an exit value of 0. The Securities and Exchange Commission (SEC) filings for IONS, MIRM, GIS, and EAT are available at the following links: IONS SEC filing on September 4, 2026, MIRM SEC filing on September 8, 2026, GIS SEC filing on July 1, 2026, and EAT SEC filing on August 12, 2026. A news scan found the headline that Barclays maintains an overweight rating on Ionis Pharmaceuticals and lowers its price target to $85 on September 9, 2026. GIS has a conference and review scheduled for September 8, 2026, at 19:00 UTC, and the fund manager will check the replay. The fund manager is also monitoring the earnings release for GIS on September 23, 2026, at 13:00 UTC, with a question-and-answer session. The baseline expectations for GIS are an EPS of $3.00-3.20 for the fiscal year 2027, with organic growth of -1.5% to +0.5% and savings of $750 million. The fund manager has set a frozen paper window from September 16 to September 21 and will review the results. EAT has an investor day scheduled for September 17, 2026, and an earnings call on October 28, 2026. The fund manager will review the results and reverify the first news release. The fund manager has set a frozen T5 holdout of -19.2065% and will not make any automatic trades. The fund manager will verify the full pipelines and early news for the stocks being monitored.

The Catalyst fund, which is for research only and has a size of 0, was updated on September 14, 2026, at 17:01:13 UTC. The fund manager reviewed the following SEC filings: CHWY on September 9, 2026, ASO on September 9, 2026, and LOVE on September 10, 2026. The manager also reviewed an 8-K filing from SFIX on July 28, 2026. Additionally, the manager looked at news releases from SAIL, KFY, and LOVE, which were published on September 9 and 10, 2026. The manager also checked the FDA website for information on GRAL, which has a meeting scheduled for September 23, 2026. The manager noted that the SEC filings may not be up to date with the latest news. The manager will review the results of LOVE on September 10, and SFIX on September 24, after the market closes on September 23. The manager also noted that the GRAL meeting on September 23 is not for approval. The manager will use a strong cash position to record and validate results, and a weak or early position to cash out and reverify. No automatic orders were placed.

A fund called Catalyst Research Only has zero size and is showing compact receipts. The information comes from the PRE91108 archive, which was accessed on 2026-09-14 at 16:01:19.848169+00:00. The system checked various news and data sources, including a news scan that found the headline 'Tamboran Delivers First Gas Sales From the Beetaloo Basin' on TBN news on September 8, 2026. It also found information about the stock CNXC, which filed a SCHEDULE 13G form on August 14, 2026. Additionally, the system looked at the corporate calendar of Tamboran and a blog post from Neovolta on home battery safety on September 9, 2026. There was also an announcement from Scholar Rock about FDA approval of ISEMBYLD on September 11, 2026. The system made decisions about stocks, including exiting NEOV on September 22 and planning to exit TBN on September 25. The system reviewed seven panels of information and calculated a unique identifier, or sha, for each one.

The fund is called Catalyst Research and it is for research only. The size of the fund is 0 and the time is 2026-09-14T15:16:09.867569+00:00. There are several news updates: TLX on Sunday, September 13, 2026, announced that the FDA approved Telix's brain cancer imaging drug Pixclara. AVO on Tuesday, September 8, 2026, announced its fiscal 2026 third-quarter financial results. ABM on Tuesday, September 8, 2026, reported its fiscal third-quarter 2026 results. ROIV on Tuesday, September 8, 2026, announced positive results from the Phocus study of mosliciguat. There are also several financial filings: UNFI filed a 10-K on September 14, 2026, DRI filed a 10-K on July 24, 2026, PPIH filed a 10-Q on September 9, 2026, MRK filed a 10-Q on August 7, 2026, and WLTH filed an 8-K on September 9, 2026. EPM declared a $0.12 per share cash dividend on Thursday, September 10, 2026. IPHA filed a 6-K on September 10, 2026. The following HTTP requests were successful: KGF with hash dda88bf6ef8ad805, ASKUL with hash e6f0d85c03a37ce6, IPHAnews with hash 63c1ed7a93468887, and SOBI with hash d719eca30b8a5a99. The research is ongoing and no orders have been placed. The monitors 165, 168, 167, and 137, and 22 will be preserved. The sources and dates are available in the job script and journal. A decision will be made on IPHA on September 17, and a receipt from Sobi is conditional on Q1-2028.

A fund manager reviewed notes from the Catalyst research fund, which has a size of 0 and compact receipts. The notes originated from the PRE91108 archive and were last updated on 2026-09-14T13:46:13.877216+00:00. The notes include six panels of information. The first panel has 71 characters and a sha code of 4a558afd719468e3. The second panel has 483 characters and a sha code of 9b319fcc0f6464f5, and it mentions a company called CNXC and a filing date of 2026-08-14. The third panel has 736 characters and a sha code of 35b7328fdf758a56, and it mentions a news article from TBN about Tamboran delivering first gas sales from the Beetaloo Basin. The fourth panel has 416 characters and a sha code of 6003fc75312f424f, and it mentions an event on the Tamboran corporate calendar. The fifth panel has 1708 characters and a sha code of 14f74c5483bcfd2a, and it mentions an FDA approval for a company called Scholar Rock. The sixth panel has 2979 characters and a sha code of 20a893bcb14321a6, and it mentions a blog post from Neovolta about home battery safety. The seventh panel has 325 characters and a sha code of 6abd1fe877acb858, and it mentions exit strategies for stocks including SRRK, NEOV, and TBN.

The Catalyst fund is currently researching IONS, MIRM, GIS, and EAT, with a size of 0. The fund's status was updated on September 14, 2026, at 12:46:05 UTC. The fund manager has reviewed SEC filings for IONS on September 4, 2026, MIRM on September 8, 2026, GIS on July 1, 2026, and EAT on August 12, 2026. A discovery was made on September 9, 2026, that Barclays maintains an overweight rating on Ionis Pharmaceuticals, but lowers its price target to $85. GIS has a conference scheduled for September 8, 2026, at 19:00 UTC, and will release its earnings on September 23, 2026, at 13:00 UTC. The fund manager will review the earnings and verify the cash flow. If the cash flow is strong, it will be recorded and validated, but if it is weak or absent, it will be reverified. No automatic entry will be made. The baseline for GIS is an EPS of $3.00-3.20, with an organic growth rate of -1.5% to +0.5%, and savings of $750 million. EAT has an investor day scheduled for September 17, 2026, and will release its earnings on October 28, 2026. The fund manager will review the earnings and verify the cash flow. If the cash flow is strong, it will be recorded and validated, but if it is weak or absent, it will be reverified. The fund manager has chosen to review the earnings on September 17, 2026, at 16:30 UTC and October 28, 2026, at 16:30 UTC. The fund is currently in research mode only, with no orders, as of September 14, 2026, at 12:46:08 UTC.

The Catalyst fund, which is for research only and has a size of 0, was updated on September 14, 2026, at 12:46:05 UTC. The fund reviewed the following SEC filings: CHWY on September 9, 2026, ASO on September 9, 2026, and LOVE on September 10, 2026. It also reviewed an 8-K filing from SFIX on July 28, 2026. Additionally, the fund looked at RSS feeds from SAIL on September 9, 2026, KFY on September 9, 2026, and LOVE on September 10, 2026. The fund also checked the FDA website for information on GRAL, which has a meeting scheduled for September 23, 2026. The fund will review new morning results on September 9, LOVE results on September 10, and SFIX results on September 24. The GRAL meeting on September 23 is not for approval. The fund has a strong cash position, which will be recorded and validated, while weak or early positions will be cashed out and reverified. No automatic orders were placed.

The fund is called Catalyst Research and it is for research only. The size of the fund is 0. This information comes from the PRE91108 archive. The information was last updated on 2026-09-14 at 11:31:15.735294+00:00. A news scan found the headline 'Tamboran Delivers First Gas Sales From the Beetaloo Basin' on TBN news on September 8, 2026. There is also information about the company CNXC, which filed a SCHEDULE 13G form on August 14, 2026. Additionally, there is information about an event on the Tamboran website. The company Neovolta posted a blog about home battery safety on September 9, 2026. Scholar Rock announced FDA approval of a drug called ISEMBYLD on September 11, 2026. There are also notes about stock prices, including SRRK, NEOV, and TBN, with specific exit dates and times, such as September 22 and September 25.

The Catalyst research fund has a size of 0 as of 2026-09-14T11:16:04.750180+00:00. Recent news includes: TLX on Sun, 13 Sep 2026, where the FDA approved Telix's brain cancer imaging drug Pixclara, which can be found at https://telixpharma.com/news-views/fda-approves-telixs-brain-cancer-imaging-drug-pixclara/. Also, AVO on Tue, 08 Sep 2026, announced fiscal 2026 third-quarter financial results at https://investors.missionproduce.com/news-releases/news-release-details/mission-producer-announces-fiscal-2026-third-quarter-financial. ABM also reported fiscal third-quarter 2026 results on Tue, 08 Sep 2026, at https://abm.gcs-web.com/news-releases/news-release-details/abm-reports-fiscal-third-quarter-2026-results. Additionally, ROIV announced positive results from the Phocus study of mosliciguat on Tue, 08 Sep 2026, at https://investor.roivant.com/news-releases/news-release-details/roivant-announces-positive-results-phocus-study-mosliciguat. The fund also reviewed financial reports from UNFI, DRI, PPIH, MRK, and WLTH. Furthermore, EPM declared a $0.12 share cash dividend for fiscal Q1 on Thu, 10 Sep 2026, at https://ir.evolutionpetroleum.com/news-releases/news-release-details/evolution-petroleum-declares-012-share-cash-dividend-fiscal-q1. IPHA filed a 6-K report on 2026-09-10, which can be found at 0001628280-26-061214/a260910_6k.htm. The fund verified the integrity of data from KGF, ASKUL, IPHAnews, and SOBI. The fund will continue to monitor IPHA until Sep 17 and Sobi's receipt and Q1-2028 conditional. The fund preserves monitors 165, 168, 167, 137, and 22. All sources and dates are recorded in the job script and journal. No orders were placed.

A fund manager reviewed six names for primary receipts, replacing 205 with an exit code of 0. The fund is called Catalyst Research and its size is 0. The information comes from the PRE91108 archive, last updated on 2026-09-14 at 09:31:12.815318 UTC. The manager looked at several news items, including a headline from TBNnews about Tamboran delivering first gas sales from the Beetaloo Basin on September 8, 2026. Another item was a filing from CNXC on August 14, 2026, which was a SCHEDULE 13G form. The manager also checked the corporate calendar of Tamboran and a blog post from Neovolta about home battery safety on September 9, 2026. Additionally, there was an announcement from Scholar Rock about FDA approval of ISEMBYLD on September 11, 2026. The manager made decisions about stocks, including exiting NEOV on September 22 and planning to exit TBN on September 25. This information comes from seven panels, each with a unique sha code, and the manager advises reading the original information before taking action.